4
Changes in Ownership
Alaunos Therapeutics, Inc. Filed Acc 0001209191-17-001014
Executive Vice President R&D gave up 21,667 shares (to pay taxes)
- Executive Vice President R&D acquired 94,350 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| LEBEL FRANCOIS Executive Vice President R&D | 2016-12-30 | Grant or award | +94,350 | 159,350 | D | ||
| LEBEL FRANCOIS Executive Vice President R&D | 2016-12-31 | Shares withheld for taxes | −21,667 | $5.35 | $115,918 | 137,683 | D |
Loading xslF345X03/doc4.xml…